Market Cap 7.85B
Revenue (ttm) 0.00
Net Income (ttm) -190.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -1.38
Volume 2,422,900
Avg Vol 1,056,506
Day's Range N/A - N/A
Shares Out 77.83M
Stochastic %K 87%
Beta 0.38
Analysts Strong Sell
Price Target $127.33

Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporat...

Industry: Biotechnology
Sector: Healthcare
Phone: 33 1 53 83 09 63
Address:
7-11 boulevard Haussmann, Paris, France
kshonstocks
kshonstocks Nov. 14 at 8:16 PM
$ABVX very good volume for a change
1 · Reply
biochirp
biochirp Nov. 14 at 7:37 PM
$PALI probably hits 6$ on $ABVX BO
0 · Reply
FE123
FE123 Nov. 14 at 7:10 PM
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Nov. 14 at 4:42 PM
$ABVX feels Like the Board has an Acceptable Offer $SLS
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Nov. 14 at 4:38 PM
$SLS The Share Price is a Gift - A market manipulated Gift Take a Look at $ABVX now at $110 up from $5 in the Days Prior to its P3 results - the ABVX Chart is the SLS Future - any day now and RESULTS BY THE END OF THE YEAR - its MID NOV. Simple Facts -- easy to understand 10,000 of these $1.44 SLS shares could be worth $500K to $1M - ANY DAY NOW - We know More than enough to Know GPS is Getting Approved. - Interim Analysis Data Cut off Nov/ Early Dec -- 12 Months ago with a 10/11 month Control Group ceiling, and ALL pooled of >13.5. GPs OS was / AT LEAST 17 months - 12 months ago, at Interim Analysis - its closer to 30 now. GPS is 100% for Sure Getting FDA Approval - and SLS is worth Multiple Billions + $25B to Big Pharma. - AVALON AML CR2 Patients on BAT MOS of 6.3 Months - ALL POOLED P3 AML CR2 MOS was N.y.M. >13.5 Months - ALL POOLED = BAT / GPS Combined >13.5 months - BAT MOS of 6.3 Months for CR2 Patients in REAL Trial Conditions.
0 · Reply
RonIsWrong
RonIsWrong Nov. 14 at 3:52 PM
$ABVX lol crazy! LFG
0 · Reply
CUBAN_CIGAR
CUBAN_CIGAR Nov. 14 at 3:35 PM
$ABVX **CDTX gets a merger from MERCK on their "BREAKTHROUGH" guess who else has a "BREAKTHROUGH" FDA letter??? LMAO, ABVX does see you above $300+ SOON
0 · Reply
RonIsWrong
RonIsWrong Nov. 14 at 3:23 PM
$ABVX hot! that volume is quite interesting!
1 · Reply
RonIsWrong
RonIsWrong Nov. 14 at 2:55 PM
$CDTX see also $ABVX
1 · Reply
BillionerOfKing
BillionerOfKing Nov. 14 at 5:20 AM
$ABVX Current Stock Price: $100.79 Contracts to trade: $100 ABVX Nov 21 2025 Call Entry: $3.40 Exit: $4.39 ROI: 29% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on ABVX
Why Is Abivax Stock Trading Higher On Monday?

Oct 6, 2025, 11:05 AM EDT - 5 weeks ago

Why Is Abivax Stock Trading Higher On Monday?


Abivax Presents First Half 2025 Financial Results

Sep 8, 2025, 4:00 PM EDT - 2 months ago

Abivax Presents First Half 2025 Financial Results


How Hedge Funds Won Big on an Obscure Drugmaker

Aug 30, 2025, 5:30 AM EDT - 2 months ago

How Hedge Funds Won Big on an Obscure Drugmaker


2 Logical Mid-Cap Biotech Buyout Targets

Aug 27, 2025, 12:50 PM EDT - 2 months ago

2 Logical Mid-Cap Biotech Buyout Targets

MLTX


Abivax Announces Closing of $747.5 Million Public Offering

Jul 28, 2025, 4:15 PM EDT - 3 months ago

Abivax Announces Closing of $747.5 Million Public Offering


Abivax Announces Launch of Public Offering

Jul 23, 2025, 4:15 PM EDT - 4 months ago

Abivax Announces Launch of Public Offering


Abivax Presents First Quarter 2025 Financial Results

Jun 2, 2025, 4:00 PM EDT - 5 months ago

Abivax Presents First Quarter 2025 Financial Results


Abivax Announces Full Year 2024 Financial Results

Mar 24, 2025, 3:30 AM EDT - 8 months ago

Abivax Announces Full Year 2024 Financial Results


Abivax Publishes 2025 Financial Calendar

Jan 28, 2025, 2:30 AM EST - 10 months ago

Abivax Publishes 2025 Financial Calendar


Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

Jan 9, 2025, 11:35 AM EST - 11 months ago

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment


Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Nov 19, 2024, 4:30 PM EST - 1 year ago

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq


Abivax presents third quarter 2024 key financial information

Nov 14, 2024, 4:01 PM EST - 1 year ago

Abivax presents third quarter 2024 key financial information


Abivax presents first-half 2024 financial results

Sep 9, 2024, 4:01 PM EDT - 1 year ago

Abivax presents first-half 2024 financial results


Abivax Provides Operational and Key Program Update

Jul 15, 2024, 4:00 PM EDT - 1 year ago

Abivax Provides Operational and Key Program Update


Abivax reports 2023 financial results and operational update

Apr 2, 2024, 2:30 AM EDT - 1 year ago

Abivax reports 2023 financial results and operational update


Citi Appointed as Depositary Bank for Abivax SA's ADR Program

Oct 26, 2023, 4:00 AM EDT - 2 years ago

Citi Appointed as Depositary Bank for Abivax SA's ADR Program


kshonstocks
kshonstocks Nov. 14 at 8:16 PM
$ABVX very good volume for a change
1 · Reply
biochirp
biochirp Nov. 14 at 7:37 PM
$PALI probably hits 6$ on $ABVX BO
0 · Reply
FE123
FE123 Nov. 14 at 7:10 PM
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Nov. 14 at 4:42 PM
$ABVX feels Like the Board has an Acceptable Offer $SLS
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Nov. 14 at 4:38 PM
$SLS The Share Price is a Gift - A market manipulated Gift Take a Look at $ABVX now at $110 up from $5 in the Days Prior to its P3 results - the ABVX Chart is the SLS Future - any day now and RESULTS BY THE END OF THE YEAR - its MID NOV. Simple Facts -- easy to understand 10,000 of these $1.44 SLS shares could be worth $500K to $1M - ANY DAY NOW - We know More than enough to Know GPS is Getting Approved. - Interim Analysis Data Cut off Nov/ Early Dec -- 12 Months ago with a 10/11 month Control Group ceiling, and ALL pooled of >13.5. GPs OS was / AT LEAST 17 months - 12 months ago, at Interim Analysis - its closer to 30 now. GPS is 100% for Sure Getting FDA Approval - and SLS is worth Multiple Billions + $25B to Big Pharma. - AVALON AML CR2 Patients on BAT MOS of 6.3 Months - ALL POOLED P3 AML CR2 MOS was N.y.M. >13.5 Months - ALL POOLED = BAT / GPS Combined >13.5 months - BAT MOS of 6.3 Months for CR2 Patients in REAL Trial Conditions.
0 · Reply
RonIsWrong
RonIsWrong Nov. 14 at 3:52 PM
$ABVX lol crazy! LFG
0 · Reply
CUBAN_CIGAR
CUBAN_CIGAR Nov. 14 at 3:35 PM
$ABVX **CDTX gets a merger from MERCK on their "BREAKTHROUGH" guess who else has a "BREAKTHROUGH" FDA letter??? LMAO, ABVX does see you above $300+ SOON
0 · Reply
RonIsWrong
RonIsWrong Nov. 14 at 3:23 PM
$ABVX hot! that volume is quite interesting!
1 · Reply
RonIsWrong
RonIsWrong Nov. 14 at 2:55 PM
$CDTX see also $ABVX
1 · Reply
BillionerOfKing
BillionerOfKing Nov. 14 at 5:20 AM
$ABVX Current Stock Price: $100.79 Contracts to trade: $100 ABVX Nov 21 2025 Call Entry: $3.40 Exit: $4.39 ROI: 29% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Nov. 13 at 1:17 PM
$SLS $75M Cash on Hand / Runway into 2028 and P3 results worth $25B Imminent. Simple Fact: when the Positive Phase 3 Top Line Results are announced - GPs Mos 24 months Control 8 we'll see 300m to 400m shares trade, and it'll wash these short Pissant lowlife lying short turdlers here now, down the drain. - All 126 patients are Now In Trial 20 + months 63 GPS and 63 Control Patients on BAT + 20 Months - 105 of them Enrolled by NOV 2023 its 24 + Months 52 GPS and 52 Control Patients on BAT + 24 Months 7 Published Trials for Patients on BAT where there is NIL Survival Past 20 months = +/- 60 EVENTS Right Now From Control - and we Wait 80.... and Consider GPS P2 MOS was 21 !!!! Hello 👋 Ask any of the Paid short lowlife working here to show you a trial where CR2 Patients are living past 20 months. meanwhile $ABVX is now. up to $108 ---
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Nov. 13 at 12:46 PM
$SLS $ABVX Short Term Share Price Warrant Manipulation offering the Investment Opportunity of a Lifetime. $100 Shares on Sale for $1.50 $220M Mcap about to Announce Registrational Phase 3 Results worth Every Nickel of $25B to Big Pharma. - GPs is about the get the Green Light to Generate Billions in Revenue - that MUST and WILL Be Reconciled by the "Market". 100X+ Potential ROI Now On the Table - could be ANY DAY - and BY the end of the Year - its already 11/12 - this is the End of the Year. . . . +/- 60 Events Just From Control Patients ... and we Wait For 80... Tick Tock...
0 · Reply
Hognose
Hognose Nov. 13 at 4:15 AM
$CPRX also a buyout candidate $ABVX another buyout candidate.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Nov. 12 at 11:18 PM
$SLS $ABVX We have Phase 3 FDA REGISTRATIONAL Trial RESULTS - that could be announced ANY DAY NOW. ALL 126 Phase 3 REGAL patients are in trial AT LEAST 20 Months + 21 + 22+ 23 Months and 105 of 'em Enrolled Nov 2023 are In Trial AT LEAST 24 months --- There is NIL Survival for AML Cr2 patients on BAT - in many trials - just No measurable OS past 20 months ... = +/- 60 Patient Events From the CONTROL Arm - and we Wait for 80.... Meanwhile -- GPS Phase 2 MOS was 21 months -- ie 50% Would have Died Buy Now - all things being Equal*. Short Term Share Price Warrant Manipulation offering the Investment Opportunity of a Lifetime. $220M Mcap about to Announce Registrational Phase 3 Results worth Every Nickel of $25B to Big Pharma. 100X + Potential ROI Now On the Table - could be ANY DAY - and BY the end of the Year - its already 11/12 - this is the End of the Year. . . . * they're not ... but still 20 Events from the GPS arm .. ...
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Nov. 12 at 10:45 PM
$SLS Couple weeks ago, SLS jumped up to $3.20 per Share After Hours on the News Black Rock Bought 5.4% of this little baby Bio ... Get Ready . . . Fully Cashed UP - runway into 2028 and on the Launch Pad for Phase 3 Results - that will be announced, any day now. REGISTRATIONAL Phase 3 Results - a FDA Green Light to Print Money - AML Remission is a $9B TAM - Just the Initial CR2 indication - is $5.55B. This $220M manipulated equity is worth $25 B to Big Pharma the Instant the P3 Results are announced. Something very similar to what happened with $ABVX is about to happen here.
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Nov. 12 at 9:36 PM
$SLS Simple Fact: when the Positive Phase 3 Top Line Results are announced - GPs Mos 24 months Control 8 we'll see 300m to 400m shares trade, and it'll wash these short Pissant lowlife turdlers here now, down the drain. - All 126 patients are Now In Trial 20 + months 63 GPS and 63 Control Patients on BAT + 20 Months - 105 of them Enrolled by NOV 2023 its 24 + Months 52 GPS and 52 Control Patients on BAT + 24 Months 7 Published Trials for Patients on BAT where there is NIL Survival Past 20 months = +/- 60 EVENTS Right Now From Control - and we Wait 80.... and Consider GPS P2 MOS was 21 !!!! Hello Ask any of the Paid short lowlife working here to show you a trial where CR2 Patients are living past 20 months. meanwhile $ABVX is now. up to $108 ---
0 · Reply
biochirp
biochirp Nov. 12 at 9:09 PM
$ABVX it’s going
1 · Reply
kshonstocks
kshonstocks Nov. 12 at 8:39 PM
$ABVX great rinse buy opptnty
0 · Reply
Zobzork
Zobzork Nov. 12 at 2:41 PM
$ABVX -1,47%. Its over boys
0 · Reply
TSLA_S3XY
TSLA_S3XY Nov. 11 at 9:44 PM
$ABVX Wish I put my money here instead of $MSTR.
0 · Reply
Lunar_Drift_28
Lunar_Drift_28 Nov. 11 at 8:51 PM
$ABVX No one’s talking ab
0 · Reply
autographic
autographic Nov. 11 at 8:19 PM
$ABVX So Strong!! 💪🏼
0 · Reply